Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
14,467,279
-
Share change
-
-1,381,080
-
Total reported value
-
$28,864,006
-
Price per share
-
$2.00
-
Number of holders
-
34
-
Value change
-
-$2,401,329
-
Number of buys
-
12
-
Number of sells
-
22
Institutional Holders of CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) as of Q3 2019
As of 30 Sep 2019,
CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,467,279 shares.
The largest 10 holders included
BVF INC/IL, Bellevue Group AG, Omega Fund Management, LLC, INTERWEST VENTURE MANAGEMENT CO, FRAZIER MANAGEMENT LLC, Aisling Capital LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, ALETHEA CAPITAL MANAGEMENT, LLC, and GRANAHAN INVESTMENT MANAGEMENT INC/MA.
This page lists
34
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.